Skip to main content
NAN 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Emily J. Rogalski, PhD (she/her/hers)

Ann Adelmann Perkins and John S. Perkins Professor of Alzheimer's Disease Prevention
Northwestern University’s Feinberg School of Medicine
Northwestern University’s Feinberg School of Medicine
Chicago, Illinois, United States

Dr. Emily Rogalski is a clinical and cognitive neuroscientist, the Ann Adelmann Perkins and John S. Perkins Professor of Alzheimer's Disease Prevention, and Associate Director of the Mesulam Center for Cognitive Neurology and Alzheimer’s Disease at Northwestern University’s Feinberg School of Medicine. She serves as Neuroimaging Biomarker Core Leader of Northwestern’s NIA-funded Alzheimer’s Disease Research Center (ADRC) and Co-Chair for the Imaging Steering Committee for the national ADRC Network. Her research falls under the broad umbrella of aging and dementia. Using a multimodal approach, she focuses her investigations on two aging perspectives: primary progressive aphasia (PPA) in which neurodegenerative disease invades the language network and SuperAging in which individuals are seemingly resistant to the deleterious changes in memory associated with “normal” or more typical cognitive aging. Her PPA research has helped to characterize the clinical and anatomical features of PPA including drivers of disease progression, identification of risk factors, and refinement of our understanding of language network organization. She has also pioneered a line of research concentrated on maximizing care and quality of life for individuals living with PPA and related dementias. She operationalized the SuperAging phenotype and has helped to establish the unique biologic, molecular, genetic, and psychosocial features associated with SuperAging. She currently leads the SuperAging Research initiative which holds promise for identifying protective factors for avoiding Alzheimer’s disease, optimizing health span, and reducing stigma and negative expectations associated with aging.

Disclosure information not submitted.

Presentation(s):